Global Mucopolysaccharidosis II Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Mucopolysaccharidosis II market size was valued at US$ million in 2023. With growing demand in downstream market, the Mucopolysaccharidosis II is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Mucopolysaccharidosis II market. Mucopolysaccharidosis II are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Mucopolysaccharidosis II. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Mucopolysaccharidosis II market.
Key Features:
The report on Mucopolysaccharidosis II market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Mucopolysaccharidosis II market. It may include historical data, market segmentation by Type (e.g., JR-141, EGT-301), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Mucopolysaccharidosis II market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Mucopolysaccharidosis II market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Mucopolysaccharidosis II industry. This include advancements in Mucopolysaccharidosis II technology, Mucopolysaccharidosis II new entrants, Mucopolysaccharidosis II new investment, and other innovations that are shaping the future of Mucopolysaccharidosis II.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Mucopolysaccharidosis II market. It includes factors influencing customer ' purchasing decisions, preferences for Mucopolysaccharidosis II product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Mucopolysaccharidosis II market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Mucopolysaccharidosis II market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Mucopolysaccharidosis II market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Mucopolysaccharidosis II industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Mucopolysaccharidosis II market.
Market Segmentation:
Mucopolysaccharidosis II market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Mucopolysaccharidosis II market?
What factors are driving Mucopolysaccharidosis II market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mucopolysaccharidosis II market opportunities vary by end market size?
How does Mucopolysaccharidosis II break out type, application?
According to our LPI (LP Information) latest study, the global Mucopolysaccharidosis II market size was valued at US$ million in 2023. With growing demand in downstream market, the Mucopolysaccharidosis II is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Mucopolysaccharidosis II market. Mucopolysaccharidosis II are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Mucopolysaccharidosis II. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Mucopolysaccharidosis II market.
Key Features:
The report on Mucopolysaccharidosis II market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Mucopolysaccharidosis II market. It may include historical data, market segmentation by Type (e.g., JR-141, EGT-301), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Mucopolysaccharidosis II market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Mucopolysaccharidosis II market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Mucopolysaccharidosis II industry. This include advancements in Mucopolysaccharidosis II technology, Mucopolysaccharidosis II new entrants, Mucopolysaccharidosis II new investment, and other innovations that are shaping the future of Mucopolysaccharidosis II.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Mucopolysaccharidosis II market. It includes factors influencing customer ' purchasing decisions, preferences for Mucopolysaccharidosis II product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Mucopolysaccharidosis II market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Mucopolysaccharidosis II market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Mucopolysaccharidosis II market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Mucopolysaccharidosis II industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Mucopolysaccharidosis II market.
Market Segmentation:
Mucopolysaccharidosis II market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- JR-141
- EGT-301
- DUOC-01
- AGT-182
- JR-032
- Others
- Hospital
- Clinic
- Research Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alexion Pharmaceuticals, Inc.
- AngioChem Inc.
- ArmaGen Inc.
- Bioasis Technologies Inc.
- Green Cross Corporation
- Inventiva
- JCR Pharmaceuticals Co., Ltd.
- Laboratorios Del Dr. Esteve S.A.
- RegenxBio Inc.
- Sangamo BioSciences, Inc.
- Takeda
What is the 10-year outlook for the global Mucopolysaccharidosis II market?
What factors are driving Mucopolysaccharidosis II market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mucopolysaccharidosis II market opportunities vary by end market size?
How does Mucopolysaccharidosis II break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mucopolysaccharidosis II Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Mucopolysaccharidosis II by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Mucopolysaccharidosis II by Country/Region, 2019, 2023 & 2030
2.2 Mucopolysaccharidosis II Segment by Type
2.2.1 JR-141
2.2.2 EGT-301
2.2.3 DUOC-01
2.2.4 AGT-182
2.2.5 JR-032
2.2.6 Others
2.3 Mucopolysaccharidosis II Sales by Type
2.3.1 Global Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
2.3.2 Global Mucopolysaccharidosis II Revenue and Market Share by Type (2019-2024)
2.3.3 Global Mucopolysaccharidosis II Sale Price by Type (2019-2024)
2.4 Mucopolysaccharidosis II Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Center
2.4.4 Others
2.5 Mucopolysaccharidosis II Sales by Application
2.5.1 Global Mucopolysaccharidosis II Sale Market Share by Application (2019-2024)
2.5.2 Global Mucopolysaccharidosis II Revenue and Market Share by Application (2019-2024)
2.5.3 Global Mucopolysaccharidosis II Sale Price by Application (2019-2024)
3 GLOBAL MUCOPOLYSACCHARIDOSIS II BY COMPANY
3.1 Global Mucopolysaccharidosis II Breakdown Data by Company
3.1.1 Global Mucopolysaccharidosis II Annual Sales by Company (2019-2024)
3.1.2 Global Mucopolysaccharidosis II Sales Market Share by Company (2019-2024)
3.2 Global Mucopolysaccharidosis II Annual Revenue by Company (2019-2024)
3.2.1 Global Mucopolysaccharidosis II Revenue by Company (2019-2024)
3.2.2 Global Mucopolysaccharidosis II Revenue Market Share by Company (2019-2024)
3.3 Global Mucopolysaccharidosis II Sale Price by Company
3.4 Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mucopolysaccharidosis II Product Location Distribution
3.4.2 Players Mucopolysaccharidosis II Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MUCOPOLYSACCHARIDOSIS II BY GEOGRAPHIC REGION
4.1 World Historic Mucopolysaccharidosis II Market Size by Geographic Region (2019-2024)
4.1.1 Global Mucopolysaccharidosis II Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Mucopolysaccharidosis II Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Mucopolysaccharidosis II Market Size by Country/Region (2019-2024)
4.2.1 Global Mucopolysaccharidosis II Annual Sales by Country/Region (2019-2024)
4.2.2 Global Mucopolysaccharidosis II Annual Revenue by Country/Region (2019-2024)
4.3 Americas Mucopolysaccharidosis II Sales Growth
4.4 APAC Mucopolysaccharidosis II Sales Growth
4.5 Europe Mucopolysaccharidosis II Sales Growth
4.6 Middle East & Africa Mucopolysaccharidosis II Sales Growth
5 AMERICAS
5.1 Americas Mucopolysaccharidosis II Sales by Country
5.1.1 Americas Mucopolysaccharidosis II Sales by Country (2019-2024)
5.1.2 Americas Mucopolysaccharidosis II Revenue by Country (2019-2024)
5.2 Americas Mucopolysaccharidosis II Sales by Type
5.3 Americas Mucopolysaccharidosis II Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mucopolysaccharidosis II Sales by Region
6.1.1 APAC Mucopolysaccharidosis II Sales by Region (2019-2024)
6.1.2 APAC Mucopolysaccharidosis II Revenue by Region (2019-2024)
6.2 APAC Mucopolysaccharidosis II Sales by Type
6.3 APAC Mucopolysaccharidosis II Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mucopolysaccharidosis II by Country
7.1.1 Europe Mucopolysaccharidosis II Sales by Country (2019-2024)
7.1.2 Europe Mucopolysaccharidosis II Revenue by Country (2019-2024)
7.2 Europe Mucopolysaccharidosis II Sales by Type
7.3 Europe Mucopolysaccharidosis II Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mucopolysaccharidosis II by Country
8.1.1 Middle East & Africa Mucopolysaccharidosis II Sales by Country (2019-2024)
8.1.2 Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2019-2024)
8.2 Middle East & Africa Mucopolysaccharidosis II Sales by Type
8.3 Middle East & Africa Mucopolysaccharidosis II Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II
10.3 Manufacturing Process Analysis of Mucopolysaccharidosis II
10.4 Industry Chain Structure of Mucopolysaccharidosis II
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mucopolysaccharidosis II Distributors
11.3 Mucopolysaccharidosis II Customer
12 WORLD FORECAST REVIEW FOR MUCOPOLYSACCHARIDOSIS II BY GEOGRAPHIC REGION
12.1 Global Mucopolysaccharidosis II Market Size Forecast by Region
12.1.1 Global Mucopolysaccharidosis II Forecast by Region (2025-2030)
12.1.2 Global Mucopolysaccharidosis II Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mucopolysaccharidosis II Forecast by Type
12.7 Global Mucopolysaccharidosis II Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Alexion Pharmaceuticals, Inc.
13.1.1 Alexion Pharmaceuticals, Inc. Company Information
13.1.2 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Alexion Pharmaceuticals, Inc. Main Business Overview
13.1.5 Alexion Pharmaceuticals, Inc. Latest Developments
13.2 AngioChem Inc.
13.2.1 AngioChem Inc. Company Information
13.2.2 AngioChem Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AngioChem Inc. Main Business Overview
13.2.5 AngioChem Inc. Latest Developments
13.3 ArmaGen Inc.
13.3.1 ArmaGen Inc. Company Information
13.3.2 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ArmaGen Inc. Main Business Overview
13.3.5 ArmaGen Inc. Latest Developments
13.4 Bioasis Technologies Inc.
13.4.1 Bioasis Technologies Inc. Company Information
13.4.2 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bioasis Technologies Inc. Main Business Overview
13.4.5 Bioasis Technologies Inc. Latest Developments
13.5 Green Cross Corporation
13.5.1 Green Cross Corporation Company Information
13.5.2 Green Cross Corporation Mucopolysaccharidosis II Product Portfolios and Specifications
13.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Green Cross Corporation Main Business Overview
13.5.5 Green Cross Corporation Latest Developments
13.6 Inventiva
13.6.1 Inventiva Company Information
13.6.2 Inventiva Mucopolysaccharidosis II Product Portfolios and Specifications
13.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Inventiva Main Business Overview
13.6.5 Inventiva Latest Developments
13.7 JCR Pharmaceuticals Co., Ltd.
13.7.1 JCR Pharmaceuticals Co., Ltd. Company Information
13.7.2 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolios and Specifications
13.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview
13.7.5 JCR Pharmaceuticals Co., Ltd. Latest Developments
13.8 Laboratorios Del Dr. Esteve S.A.
13.8.1 Laboratorios Del Dr. Esteve S.A. Company Information
13.8.2 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolios and Specifications
13.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Laboratorios Del Dr. Esteve S.A. Main Business Overview
13.8.5 Laboratorios Del Dr. Esteve S.A. Latest Developments
13.9 RegenxBio Inc.
13.9.1 RegenxBio Inc. Company Information
13.9.2 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 RegenxBio Inc. Main Business Overview
13.9.5 RegenxBio Inc. Latest Developments
13.10 Sangamo BioSciences, Inc.
13.10.1 Sangamo BioSciences, Inc. Company Information
13.10.2 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Sangamo BioSciences, Inc. Main Business Overview
13.10.5 Sangamo BioSciences, Inc. Latest Developments
13.11 Takeda
13.11.1 Takeda Company Information
13.11.2 Takeda Mucopolysaccharidosis II Product Portfolios and Specifications
13.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Takeda Main Business Overview
13.11.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mucopolysaccharidosis II Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Mucopolysaccharidosis II by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Mucopolysaccharidosis II by Country/Region, 2019, 2023 & 2030
2.2 Mucopolysaccharidosis II Segment by Type
2.2.1 JR-141
2.2.2 EGT-301
2.2.3 DUOC-01
2.2.4 AGT-182
2.2.5 JR-032
2.2.6 Others
2.3 Mucopolysaccharidosis II Sales by Type
2.3.1 Global Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
2.3.2 Global Mucopolysaccharidosis II Revenue and Market Share by Type (2019-2024)
2.3.3 Global Mucopolysaccharidosis II Sale Price by Type (2019-2024)
2.4 Mucopolysaccharidosis II Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Center
2.4.4 Others
2.5 Mucopolysaccharidosis II Sales by Application
2.5.1 Global Mucopolysaccharidosis II Sale Market Share by Application (2019-2024)
2.5.2 Global Mucopolysaccharidosis II Revenue and Market Share by Application (2019-2024)
2.5.3 Global Mucopolysaccharidosis II Sale Price by Application (2019-2024)
3 GLOBAL MUCOPOLYSACCHARIDOSIS II BY COMPANY
3.1 Global Mucopolysaccharidosis II Breakdown Data by Company
3.1.1 Global Mucopolysaccharidosis II Annual Sales by Company (2019-2024)
3.1.2 Global Mucopolysaccharidosis II Sales Market Share by Company (2019-2024)
3.2 Global Mucopolysaccharidosis II Annual Revenue by Company (2019-2024)
3.2.1 Global Mucopolysaccharidosis II Revenue by Company (2019-2024)
3.2.2 Global Mucopolysaccharidosis II Revenue Market Share by Company (2019-2024)
3.3 Global Mucopolysaccharidosis II Sale Price by Company
3.4 Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mucopolysaccharidosis II Product Location Distribution
3.4.2 Players Mucopolysaccharidosis II Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MUCOPOLYSACCHARIDOSIS II BY GEOGRAPHIC REGION
4.1 World Historic Mucopolysaccharidosis II Market Size by Geographic Region (2019-2024)
4.1.1 Global Mucopolysaccharidosis II Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Mucopolysaccharidosis II Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Mucopolysaccharidosis II Market Size by Country/Region (2019-2024)
4.2.1 Global Mucopolysaccharidosis II Annual Sales by Country/Region (2019-2024)
4.2.2 Global Mucopolysaccharidosis II Annual Revenue by Country/Region (2019-2024)
4.3 Americas Mucopolysaccharidosis II Sales Growth
4.4 APAC Mucopolysaccharidosis II Sales Growth
4.5 Europe Mucopolysaccharidosis II Sales Growth
4.6 Middle East & Africa Mucopolysaccharidosis II Sales Growth
5 AMERICAS
5.1 Americas Mucopolysaccharidosis II Sales by Country
5.1.1 Americas Mucopolysaccharidosis II Sales by Country (2019-2024)
5.1.2 Americas Mucopolysaccharidosis II Revenue by Country (2019-2024)
5.2 Americas Mucopolysaccharidosis II Sales by Type
5.3 Americas Mucopolysaccharidosis II Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mucopolysaccharidosis II Sales by Region
6.1.1 APAC Mucopolysaccharidosis II Sales by Region (2019-2024)
6.1.2 APAC Mucopolysaccharidosis II Revenue by Region (2019-2024)
6.2 APAC Mucopolysaccharidosis II Sales by Type
6.3 APAC Mucopolysaccharidosis II Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mucopolysaccharidosis II by Country
7.1.1 Europe Mucopolysaccharidosis II Sales by Country (2019-2024)
7.1.2 Europe Mucopolysaccharidosis II Revenue by Country (2019-2024)
7.2 Europe Mucopolysaccharidosis II Sales by Type
7.3 Europe Mucopolysaccharidosis II Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mucopolysaccharidosis II by Country
8.1.1 Middle East & Africa Mucopolysaccharidosis II Sales by Country (2019-2024)
8.1.2 Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2019-2024)
8.2 Middle East & Africa Mucopolysaccharidosis II Sales by Type
8.3 Middle East & Africa Mucopolysaccharidosis II Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II
10.3 Manufacturing Process Analysis of Mucopolysaccharidosis II
10.4 Industry Chain Structure of Mucopolysaccharidosis II
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mucopolysaccharidosis II Distributors
11.3 Mucopolysaccharidosis II Customer
12 WORLD FORECAST REVIEW FOR MUCOPOLYSACCHARIDOSIS II BY GEOGRAPHIC REGION
12.1 Global Mucopolysaccharidosis II Market Size Forecast by Region
12.1.1 Global Mucopolysaccharidosis II Forecast by Region (2025-2030)
12.1.2 Global Mucopolysaccharidosis II Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mucopolysaccharidosis II Forecast by Type
12.7 Global Mucopolysaccharidosis II Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Alexion Pharmaceuticals, Inc.
13.1.1 Alexion Pharmaceuticals, Inc. Company Information
13.1.2 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Alexion Pharmaceuticals, Inc. Main Business Overview
13.1.5 Alexion Pharmaceuticals, Inc. Latest Developments
13.2 AngioChem Inc.
13.2.1 AngioChem Inc. Company Information
13.2.2 AngioChem Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AngioChem Inc. Main Business Overview
13.2.5 AngioChem Inc. Latest Developments
13.3 ArmaGen Inc.
13.3.1 ArmaGen Inc. Company Information
13.3.2 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ArmaGen Inc. Main Business Overview
13.3.5 ArmaGen Inc. Latest Developments
13.4 Bioasis Technologies Inc.
13.4.1 Bioasis Technologies Inc. Company Information
13.4.2 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bioasis Technologies Inc. Main Business Overview
13.4.5 Bioasis Technologies Inc. Latest Developments
13.5 Green Cross Corporation
13.5.1 Green Cross Corporation Company Information
13.5.2 Green Cross Corporation Mucopolysaccharidosis II Product Portfolios and Specifications
13.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Green Cross Corporation Main Business Overview
13.5.5 Green Cross Corporation Latest Developments
13.6 Inventiva
13.6.1 Inventiva Company Information
13.6.2 Inventiva Mucopolysaccharidosis II Product Portfolios and Specifications
13.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Inventiva Main Business Overview
13.6.5 Inventiva Latest Developments
13.7 JCR Pharmaceuticals Co., Ltd.
13.7.1 JCR Pharmaceuticals Co., Ltd. Company Information
13.7.2 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolios and Specifications
13.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview
13.7.5 JCR Pharmaceuticals Co., Ltd. Latest Developments
13.8 Laboratorios Del Dr. Esteve S.A.
13.8.1 Laboratorios Del Dr. Esteve S.A. Company Information
13.8.2 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolios and Specifications
13.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Laboratorios Del Dr. Esteve S.A. Main Business Overview
13.8.5 Laboratorios Del Dr. Esteve S.A. Latest Developments
13.9 RegenxBio Inc.
13.9.1 RegenxBio Inc. Company Information
13.9.2 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 RegenxBio Inc. Main Business Overview
13.9.5 RegenxBio Inc. Latest Developments
13.10 Sangamo BioSciences, Inc.
13.10.1 Sangamo BioSciences, Inc. Company Information
13.10.2 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Sangamo BioSciences, Inc. Main Business Overview
13.10.5 Sangamo BioSciences, Inc. Latest Developments
13.11 Takeda
13.11.1 Takeda Company Information
13.11.2 Takeda Mucopolysaccharidosis II Product Portfolios and Specifications
13.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Takeda Main Business Overview
13.11.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mucopolysaccharidosis II Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Mucopolysaccharidosis II Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of JR-141
Table 4. Major Players of EGT-301
Table 5. Major Players of DUOC-01
Table 6. Major Players of AGT-182
Table 7. Major Players of JR-032
Table 8. Major Players of Others
Table 9. Global Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 10. Global Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Table 11. Global Mucopolysaccharidosis II Revenue by Type (2019-2024) & ($ million)
Table 12. Global Mucopolysaccharidosis II Revenue Market Share by Type (2019-2024)
Table 13. Global Mucopolysaccharidosis II Sale Price by Type (2019-2024) & (USD/Pcs)
Table 14. Global Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 15. Global Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Table 16. Global Mucopolysaccharidosis II Revenue by Application (2019-2024)
Table 17. Global Mucopolysaccharidosis II Revenue Market Share by Application (2019-2024)
Table 18. Global Mucopolysaccharidosis II Sale Price by Application (2019-2024) & (USD/Pcs)
Table 19. Global Mucopolysaccharidosis II Sales by Company (2019-2024) & (K Pcs)
Table 20. Global Mucopolysaccharidosis II Sales Market Share by Company (2019-2024)
Table 21. Global Mucopolysaccharidosis II Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Mucopolysaccharidosis II Revenue Market Share by Company (2019-2024)
Table 23. Global Mucopolysaccharidosis II Sale Price by Company (2019-2024) & (USD/Pcs)
Table 24. Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution and Sales Area
Table 25. Players Mucopolysaccharidosis II Products Offered
Table 26. Mucopolysaccharidosis II Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Mucopolysaccharidosis II Sales by Geographic Region (2019-2024) & (K Pcs)
Table 30. Global Mucopolysaccharidosis II Sales Market Share Geographic Region (2019-2024)
Table 31. Global Mucopolysaccharidosis II Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Mucopolysaccharidosis II Sales by Country/Region (2019-2024) & (K Pcs)
Table 34. Global Mucopolysaccharidosis II Sales Market Share by Country/Region (2019-2024)
Table 35. Global Mucopolysaccharidosis II Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Mucopolysaccharidosis II Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Mucopolysaccharidosis II Sales by Country (2019-2024) & (K Pcs)
Table 38. Americas Mucopolysaccharidosis II Sales Market Share by Country (2019-2024)
Table 39. Americas Mucopolysaccharidosis II Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Mucopolysaccharidosis II Revenue Market Share by Country (2019-2024)
Table 41. Americas Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 42. Americas Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 43. APAC Mucopolysaccharidosis II Sales by Region (2019-2024) & (K Pcs)
Table 44. APAC Mucopolysaccharidosis II Sales Market Share by Region (2019-2024)
Table 45. APAC Mucopolysaccharidosis II Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Mucopolysaccharidosis II Revenue Market Share by Region (2019-2024)
Table 47. APAC Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 48. APAC Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 49. Europe Mucopolysaccharidosis II Sales by Country (2019-2024) & (K Pcs)
Table 50. Europe Mucopolysaccharidosis II Sales Market Share by Country (2019-2024)
Table 51. Europe Mucopolysaccharidosis II Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Mucopolysaccharidosis II Revenue Market Share by Country (2019-2024)
Table 53. Europe Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 54. Europe Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 55. Middle East & Africa Mucopolysaccharidosis II Sales by Country (2019-2024) & (K Pcs)
Table 56. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 60. Middle East & Africa Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 61. Key Market Drivers & Growth Opportunities of Mucopolysaccharidosis II
Table 62. Key Market Challenges & Risks of Mucopolysaccharidosis II
Table 63. Key Industry Trends of Mucopolysaccharidosis II
Table 64. Mucopolysaccharidosis II Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Mucopolysaccharidosis II Distributors List
Table 67. Mucopolysaccharidosis II Customer List
Table 68. Global Mucopolysaccharidosis II Sales Forecast by Region (2025-2030) & (K Pcs)
Table 69. Global Mucopolysaccharidosis II Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Mucopolysaccharidosis II Sales Forecast by Country (2025-2030) & (K Pcs)
Table 71. Americas Mucopolysaccharidosis II Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Mucopolysaccharidosis II Sales Forecast by Region (2025-2030) & (K Pcs)
Table 73. APAC Mucopolysaccharidosis II Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Mucopolysaccharidosis II Sales Forecast by Country (2025-2030) & (K Pcs)
Table 75. Europe Mucopolysaccharidosis II Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Mucopolysaccharidosis II Sales Forecast by Country (2025-2030) & (K Pcs)
Table 77. Middle East & Africa Mucopolysaccharidosis II Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Mucopolysaccharidosis II Sales Forecast by Type (2025-2030) & (K Pcs)
Table 79. Global Mucopolysaccharidosis II Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Mucopolysaccharidosis II Sales Forecast by Application (2025-2030) & (K Pcs)
Table 81. Global Mucopolysaccharidosis II Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Alexion Pharmaceuticals, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 83. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 84. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 85. Alexion Pharmaceuticals, Inc. Main Business
Table 86. Alexion Pharmaceuticals, Inc. Latest Developments
Table 87. AngioChem Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 88. AngioChem Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 89. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 90. AngioChem Inc. Main Business
Table 91. AngioChem Inc. Latest Developments
Table 92. ArmaGen Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 93. ArmaGen Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 94. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 95. ArmaGen Inc. Main Business
Table 96. ArmaGen Inc. Latest Developments
Table 97. Bioasis Technologies Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 98. Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 99. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 100. Bioasis Technologies Inc. Main Business
Table 101. Bioasis Technologies Inc. Latest Developments
Table 102. Green Cross Corporation Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 103. Green Cross Corporation Mucopolysaccharidosis II Product Portfolios and Specifications
Table 104. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 105. Green Cross Corporation Main Business
Table 106. Green Cross Corporation Latest Developments
Table 107. Inventiva Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 108. Inventiva Mucopolysaccharidosis II Product Portfolios and Specifications
Table 109. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 110. Inventiva Main Business
Table 111. Inventiva Latest Developments
Table 112. JCR Pharmaceuticals Co., Ltd. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 113. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 114. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 115. JCR Pharmaceuticals Co., Ltd. Main Business
Table 116. JCR Pharmaceuticals Co., Ltd. Latest Developments
Table 117. Laboratorios Del Dr. Esteve S.A. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 118. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 119. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 120. Laboratorios Del Dr. Esteve S.A. Main Business
Table 121. Laboratorios Del Dr. Esteve S.A. Latest Developments
Table 122. RegenxBio Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 123. RegenxBio Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 124. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 125. RegenxBio Inc. Main Business
Table 126. RegenxBio Inc. Latest Developments
Table 127. Sangamo BioSciences, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 128. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 129. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 130. Sangamo BioSciences, Inc. Main Business
Table 131. Sangamo BioSciences, Inc. Latest Developments
Table 132. Takeda Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 133. Takeda Mucopolysaccharidosis II Product Portfolios and Specifications
Table 134. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 135. Takeda Main Business
Table 136. Takeda Latest Developments
Table 1. Mucopolysaccharidosis II Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Mucopolysaccharidosis II Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of JR-141
Table 4. Major Players of EGT-301
Table 5. Major Players of DUOC-01
Table 6. Major Players of AGT-182
Table 7. Major Players of JR-032
Table 8. Major Players of Others
Table 9. Global Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 10. Global Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Table 11. Global Mucopolysaccharidosis II Revenue by Type (2019-2024) & ($ million)
Table 12. Global Mucopolysaccharidosis II Revenue Market Share by Type (2019-2024)
Table 13. Global Mucopolysaccharidosis II Sale Price by Type (2019-2024) & (USD/Pcs)
Table 14. Global Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 15. Global Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Table 16. Global Mucopolysaccharidosis II Revenue by Application (2019-2024)
Table 17. Global Mucopolysaccharidosis II Revenue Market Share by Application (2019-2024)
Table 18. Global Mucopolysaccharidosis II Sale Price by Application (2019-2024) & (USD/Pcs)
Table 19. Global Mucopolysaccharidosis II Sales by Company (2019-2024) & (K Pcs)
Table 20. Global Mucopolysaccharidosis II Sales Market Share by Company (2019-2024)
Table 21. Global Mucopolysaccharidosis II Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Mucopolysaccharidosis II Revenue Market Share by Company (2019-2024)
Table 23. Global Mucopolysaccharidosis II Sale Price by Company (2019-2024) & (USD/Pcs)
Table 24. Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution and Sales Area
Table 25. Players Mucopolysaccharidosis II Products Offered
Table 26. Mucopolysaccharidosis II Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Mucopolysaccharidosis II Sales by Geographic Region (2019-2024) & (K Pcs)
Table 30. Global Mucopolysaccharidosis II Sales Market Share Geographic Region (2019-2024)
Table 31. Global Mucopolysaccharidosis II Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Mucopolysaccharidosis II Sales by Country/Region (2019-2024) & (K Pcs)
Table 34. Global Mucopolysaccharidosis II Sales Market Share by Country/Region (2019-2024)
Table 35. Global Mucopolysaccharidosis II Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Mucopolysaccharidosis II Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Mucopolysaccharidosis II Sales by Country (2019-2024) & (K Pcs)
Table 38. Americas Mucopolysaccharidosis II Sales Market Share by Country (2019-2024)
Table 39. Americas Mucopolysaccharidosis II Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Mucopolysaccharidosis II Revenue Market Share by Country (2019-2024)
Table 41. Americas Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 42. Americas Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 43. APAC Mucopolysaccharidosis II Sales by Region (2019-2024) & (K Pcs)
Table 44. APAC Mucopolysaccharidosis II Sales Market Share by Region (2019-2024)
Table 45. APAC Mucopolysaccharidosis II Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Mucopolysaccharidosis II Revenue Market Share by Region (2019-2024)
Table 47. APAC Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 48. APAC Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 49. Europe Mucopolysaccharidosis II Sales by Country (2019-2024) & (K Pcs)
Table 50. Europe Mucopolysaccharidosis II Sales Market Share by Country (2019-2024)
Table 51. Europe Mucopolysaccharidosis II Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Mucopolysaccharidosis II Revenue Market Share by Country (2019-2024)
Table 53. Europe Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 54. Europe Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 55. Middle East & Africa Mucopolysaccharidosis II Sales by Country (2019-2024) & (K Pcs)
Table 56. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Mucopolysaccharidosis II Sales by Type (2019-2024) & (K Pcs)
Table 60. Middle East & Africa Mucopolysaccharidosis II Sales by Application (2019-2024) & (K Pcs)
Table 61. Key Market Drivers & Growth Opportunities of Mucopolysaccharidosis II
Table 62. Key Market Challenges & Risks of Mucopolysaccharidosis II
Table 63. Key Industry Trends of Mucopolysaccharidosis II
Table 64. Mucopolysaccharidosis II Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Mucopolysaccharidosis II Distributors List
Table 67. Mucopolysaccharidosis II Customer List
Table 68. Global Mucopolysaccharidosis II Sales Forecast by Region (2025-2030) & (K Pcs)
Table 69. Global Mucopolysaccharidosis II Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Mucopolysaccharidosis II Sales Forecast by Country (2025-2030) & (K Pcs)
Table 71. Americas Mucopolysaccharidosis II Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Mucopolysaccharidosis II Sales Forecast by Region (2025-2030) & (K Pcs)
Table 73. APAC Mucopolysaccharidosis II Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Mucopolysaccharidosis II Sales Forecast by Country (2025-2030) & (K Pcs)
Table 75. Europe Mucopolysaccharidosis II Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Mucopolysaccharidosis II Sales Forecast by Country (2025-2030) & (K Pcs)
Table 77. Middle East & Africa Mucopolysaccharidosis II Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Mucopolysaccharidosis II Sales Forecast by Type (2025-2030) & (K Pcs)
Table 79. Global Mucopolysaccharidosis II Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Mucopolysaccharidosis II Sales Forecast by Application (2025-2030) & (K Pcs)
Table 81. Global Mucopolysaccharidosis II Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Alexion Pharmaceuticals, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 83. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 84. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 85. Alexion Pharmaceuticals, Inc. Main Business
Table 86. Alexion Pharmaceuticals, Inc. Latest Developments
Table 87. AngioChem Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 88. AngioChem Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 89. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 90. AngioChem Inc. Main Business
Table 91. AngioChem Inc. Latest Developments
Table 92. ArmaGen Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 93. ArmaGen Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 94. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 95. ArmaGen Inc. Main Business
Table 96. ArmaGen Inc. Latest Developments
Table 97. Bioasis Technologies Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 98. Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 99. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 100. Bioasis Technologies Inc. Main Business
Table 101. Bioasis Technologies Inc. Latest Developments
Table 102. Green Cross Corporation Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 103. Green Cross Corporation Mucopolysaccharidosis II Product Portfolios and Specifications
Table 104. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 105. Green Cross Corporation Main Business
Table 106. Green Cross Corporation Latest Developments
Table 107. Inventiva Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 108. Inventiva Mucopolysaccharidosis II Product Portfolios and Specifications
Table 109. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 110. Inventiva Main Business
Table 111. Inventiva Latest Developments
Table 112. JCR Pharmaceuticals Co., Ltd. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 113. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 114. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 115. JCR Pharmaceuticals Co., Ltd. Main Business
Table 116. JCR Pharmaceuticals Co., Ltd. Latest Developments
Table 117. Laboratorios Del Dr. Esteve S.A. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 118. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 119. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 120. Laboratorios Del Dr. Esteve S.A. Main Business
Table 121. Laboratorios Del Dr. Esteve S.A. Latest Developments
Table 122. RegenxBio Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 123. RegenxBio Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 124. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 125. RegenxBio Inc. Main Business
Table 126. RegenxBio Inc. Latest Developments
Table 127. Sangamo BioSciences, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 128. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 129. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 130. Sangamo BioSciences, Inc. Main Business
Table 131. Sangamo BioSciences, Inc. Latest Developments
Table 132. Takeda Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 133. Takeda Mucopolysaccharidosis II Product Portfolios and Specifications
Table 134. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 135. Takeda Main Business
Table 136. Takeda Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mucopolysaccharidosis II
Figure 2. Mucopolysaccharidosis II Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mucopolysaccharidosis II Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Mucopolysaccharidosis II Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Mucopolysaccharidosis II Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of JR-141
Figure 10. Product Picture of EGT-301
Figure 11. Product Picture of DUOC-01
Figure 12. Product Picture of AGT-182
Figure 13. Product Picture of JR-032
Figure 14. Product Picture of Others
Figure 15. Global Mucopolysaccharidosis II Sales Market Share by Type in 2023
Figure 16. Global Mucopolysaccharidosis II Revenue Market Share by Type (2019-2024)
Figure 17. Mucopolysaccharidosis II Consumed in Hospital
Figure 18. Global Mucopolysaccharidosis II Market: Hospital (2019-2024) & (K Pcs)
Figure 19. Mucopolysaccharidosis II Consumed in Clinic
Figure 20. Global Mucopolysaccharidosis II Market: Clinic (2019-2024) & (K Pcs)
Figure 21. Mucopolysaccharidosis II Consumed in Research Center
Figure 22. Global Mucopolysaccharidosis II Market: Research Center (2019-2024) & (K Pcs)
Figure 23. Mucopolysaccharidosis II Consumed in Others
Figure 24. Global Mucopolysaccharidosis II Market: Others (2019-2024) & (K Pcs)
Figure 25. Global Mucopolysaccharidosis II Sales Market Share by Application (2023)
Figure 26. Global Mucopolysaccharidosis II Revenue Market Share by Application in 2023
Figure 27. Mucopolysaccharidosis II Sales Market by Company in 2023 (K Pcs)
Figure 28. Global Mucopolysaccharidosis II Sales Market Share by Company in 2023
Figure 29. Mucopolysaccharidosis II Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Mucopolysaccharidosis II Revenue Market Share by Company in 2023
Figure 31. Global Mucopolysaccharidosis II Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Mucopolysaccharidosis II Sales 2019-2024 (K Pcs)
Figure 34. Americas Mucopolysaccharidosis II Revenue 2019-2024 ($ Millions)
Figure 35. APAC Mucopolysaccharidosis II Sales 2019-2024 (K Pcs)
Figure 36. APAC Mucopolysaccharidosis II Revenue 2019-2024 ($ Millions)
Figure 37. Europe Mucopolysaccharidosis II Sales 2019-2024 (K Pcs)
Figure 38. Europe Mucopolysaccharidosis II Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Mucopolysaccharidosis II Sales 2019-2024 (K Pcs)
Figure 40. Middle East & Africa Mucopolysaccharidosis II Revenue 2019-2024 ($ Millions)
Figure 41. Americas Mucopolysaccharidosis II Sales Market Share by Country in 2023
Figure 42. Americas Mucopolysaccharidosis II Revenue Market Share by Country in 2023
Figure 43. Americas Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Figure 44. Americas Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Figure 45. United States Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Mucopolysaccharidosis II Sales Market Share by Region in 2023
Figure 50. APAC Mucopolysaccharidosis II Revenue Market Share by Regions in 2023
Figure 51. APAC Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Figure 52. APAC Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Figure 53. China Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Mucopolysaccharidosis II Sales Market Share by Country in 2023
Figure 61. Europe Mucopolysaccharidosis II Revenue Market Share by Country in 2023
Figure 62. Europe Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Figure 63. Europe Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Figure 64. Germany Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Figure 73. Egypt Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II in 2023
Figure 79. Manufacturing Process Analysis of Mucopolysaccharidosis II
Figure 80. Industry Chain Structure of Mucopolysaccharidosis II
Figure 81. Channels of Distribution
Figure 82. Global Mucopolysaccharidosis II Sales Market Forecast by Region (2025-2030)
Figure 83. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Mucopolysaccharidosis II Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Mucopolysaccharidosis II Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Mucopolysaccharidosis II
Figure 2. Mucopolysaccharidosis II Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mucopolysaccharidosis II Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Mucopolysaccharidosis II Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Mucopolysaccharidosis II Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of JR-141
Figure 10. Product Picture of EGT-301
Figure 11. Product Picture of DUOC-01
Figure 12. Product Picture of AGT-182
Figure 13. Product Picture of JR-032
Figure 14. Product Picture of Others
Figure 15. Global Mucopolysaccharidosis II Sales Market Share by Type in 2023
Figure 16. Global Mucopolysaccharidosis II Revenue Market Share by Type (2019-2024)
Figure 17. Mucopolysaccharidosis II Consumed in Hospital
Figure 18. Global Mucopolysaccharidosis II Market: Hospital (2019-2024) & (K Pcs)
Figure 19. Mucopolysaccharidosis II Consumed in Clinic
Figure 20. Global Mucopolysaccharidosis II Market: Clinic (2019-2024) & (K Pcs)
Figure 21. Mucopolysaccharidosis II Consumed in Research Center
Figure 22. Global Mucopolysaccharidosis II Market: Research Center (2019-2024) & (K Pcs)
Figure 23. Mucopolysaccharidosis II Consumed in Others
Figure 24. Global Mucopolysaccharidosis II Market: Others (2019-2024) & (K Pcs)
Figure 25. Global Mucopolysaccharidosis II Sales Market Share by Application (2023)
Figure 26. Global Mucopolysaccharidosis II Revenue Market Share by Application in 2023
Figure 27. Mucopolysaccharidosis II Sales Market by Company in 2023 (K Pcs)
Figure 28. Global Mucopolysaccharidosis II Sales Market Share by Company in 2023
Figure 29. Mucopolysaccharidosis II Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Mucopolysaccharidosis II Revenue Market Share by Company in 2023
Figure 31. Global Mucopolysaccharidosis II Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Mucopolysaccharidosis II Sales 2019-2024 (K Pcs)
Figure 34. Americas Mucopolysaccharidosis II Revenue 2019-2024 ($ Millions)
Figure 35. APAC Mucopolysaccharidosis II Sales 2019-2024 (K Pcs)
Figure 36. APAC Mucopolysaccharidosis II Revenue 2019-2024 ($ Millions)
Figure 37. Europe Mucopolysaccharidosis II Sales 2019-2024 (K Pcs)
Figure 38. Europe Mucopolysaccharidosis II Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Mucopolysaccharidosis II Sales 2019-2024 (K Pcs)
Figure 40. Middle East & Africa Mucopolysaccharidosis II Revenue 2019-2024 ($ Millions)
Figure 41. Americas Mucopolysaccharidosis II Sales Market Share by Country in 2023
Figure 42. Americas Mucopolysaccharidosis II Revenue Market Share by Country in 2023
Figure 43. Americas Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Figure 44. Americas Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Figure 45. United States Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Mucopolysaccharidosis II Sales Market Share by Region in 2023
Figure 50. APAC Mucopolysaccharidosis II Revenue Market Share by Regions in 2023
Figure 51. APAC Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Figure 52. APAC Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Figure 53. China Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Mucopolysaccharidosis II Sales Market Share by Country in 2023
Figure 61. Europe Mucopolysaccharidosis II Revenue Market Share by Country in 2023
Figure 62. Europe Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Figure 63. Europe Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Figure 64. Germany Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Application (2019-2024)
Figure 73. Egypt Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Mucopolysaccharidosis II Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II in 2023
Figure 79. Manufacturing Process Analysis of Mucopolysaccharidosis II
Figure 80. Industry Chain Structure of Mucopolysaccharidosis II
Figure 81. Channels of Distribution
Figure 82. Global Mucopolysaccharidosis II Sales Market Forecast by Region (2025-2030)
Figure 83. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Mucopolysaccharidosis II Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Mucopolysaccharidosis II Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Application (2025-2030)
